CoChat

Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease

Open access
Hill, Derek L.G., Schwarz, Adam J., Isaac, Maria, Pani, Luca, Vamvakas, Spiros, Hemmings, Robert, Carrillo, Maria C., Yu, Peng, Sun, Jia, Beckett, Laurel, Boccardi, Marina, Brewer, James, Brumfield, Martha, Cantillon, Marc, Cole, Patricia E., Fox, Nick, Frisoni, Giovanni B., Jack, Clifford, Kelleher, Thomas, Luo, Feng, Novak, Gerald, Maguire, Paul, Meibach, Richard, Patterson, Patricia, Bain, Lisa, Sampaio, Cristina, Raunig, David, Soares, Holly, Suhy, Joyce, Wang, Huanli, Wolz, Robin, Stephenson, Diane · 2014 · Alzheimer's & Dementia
Cited by 96

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background: Regulatory qualification of a biomarker for a defined context of use provides scientifically robust assurances to sponsors and regulators that accelerate appropriate adoption of biomarkers into drug development. Methods: The Coalition Against Major Diseases submitted a dossier to the Scientific Advice Working Party of the European Medicines Agency requesting a qualification opinion on the use of hippocampal volume as a biomarker for enriching clinical trials in subjects with mild cognitive impairment, incorporating a scientific rationale, a literature review and a de novo analysis of Alzheimer's Disease Neuroimaging Initiative data. Results: The literature review and de novo analysis were consistent with the proposed context of use, and the Committee for Medicinal Products for Human Use released an opinion in November 2011. Conclusions: We summarize the scientific rationale and the data that supported the first qualification of an imaging biomarker by the European Medicines Agency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2013.07.003

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 96

Metadata

Authors
Hill, D. L. G., Schwarz, A. J., Isaac, M., Pani, L., Vamvakas, S., Hemmings, R., Carrillo, M. C., Yu, P., Sun, J., Beckett, L., Boccardi, M., Brewer, J., Brumfield, M., Cantillon, M., Cole, P. E., Fox, N., Frisoni, G. B., Jack, C., Kelleher, T., Luo, F., Novak, G., Maguire, P., Meibach, R., Patterson, P., Bain, L., Sampaio, C., Raunig, D., Soares, H., Suhy, J., Wang, H., Wolz, R., & Stephenson, D.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2014-07
Volume
10
Issue
4
Pages
421
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2056733711
Cited by
96
References
18
FWCI
8.09
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.jalz.2013.07.003
The paper
Hill, D. L. G., Schwarz, A. J., Isaac, M., Pani, L., Vamvakas, S., Hemmings, R., Carrillo, M. C., Yu, P., Sun, J., Beckett, L., Boccardi, M., Brewer, J., Brumfield, M., Cantillon, M., Cole, P. E., Fox, N., Frisoni, G. B., Jack, C., Kelleher, T., . . . Stephenson, D. (2014). Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2013.07.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.